| Nafarelin |
| (D-2-Nal6)-LHRH |
| (CAS 76932-56-4) |
 |
| Description： |
Nafarelin is a gonadotropin-releasing hormone agonist (GnRH agonist). By causing constant stimulation of the pituitary gland, it decreases pituitary secretion of the gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Nafarelin may be used in the treatment of estrogen-dependent conditions (such as endometriosis or uterine fibroids), to treat central precocious puberty, or to control ovarian stimulation in IVF.
Nafarelin acetate is marketed by Searle (now part of Pfizer) under the brand name Synarel. It is delivered via a nasal spray.
|
| Product No. |
KT10058 |
| Product Name |
Nafarelin |
| Synonyms |
(D-2-Nal6)-LHRH;Luteinizinghormone-releasing factor (pig), 6-[3-(2-naphthalenyl)-D-alanine]-;NAG;Nafareline;[6-D-(2-naphthyl)-alanine]LH-RH;Luteinizinghormone-releasing factor (swine), 6-[3-(2-naphtha |
| Formal Name |
(D-2-Nal6)-LHRH |
| CAS Number |
76932-56-4 |
| Molecular Formula |
C66H83N17O13 |
| Formula Weight |
1322.48 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
Lipopeptide Acetate
Liraglutide
Lixisenatide
Lysipressin Acetate
Matrixyl
Melanotan II
Nafarelin Acetate
Nesiritide Acetate （BNP-32）
Octreotide
Octreotide acetate
Ornipressin Acetate
Vapreotide Acetate
Vapreotide acetate
Vasopressin Acetate
Ziconotide acetate
|
|
